Skip to main content
Top

Current Oncology Reports

Issue 1/2024

Content (9 Articles)

Racial Disparities in Breast Cancer: from Detection to Treatment

JC Chen, Daniel G. Stover, Tarah J. Ballinger, Jose G. Bazan, Bryan P. Schneider, Barbara L. Andersen, William E. Carson, Samilia Obeng-Gyasi

Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?

Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa Lynce, Sara M. Tolaney, Ilana Schlam

Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship

Prarthna V Bhardwaj, Shilpi Gupta, Alexa Elyash, Eleonora Teplinsky

Open Access Ovarian Cancer

Surgery for Recurrent Epithelial Ovarian Cancer

Christina Fotopoulou, Ane Gerda Eriksson, Itai Yagel, Suk-Joon Chang, Myong Cheol Lim

Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer

Arthur Streit, Savvas Lampridis, Joseph Seitlinger, Stéphane Renaud, Tom Routledge, Andrea Bille

Open Access NSCLC REVIEW

Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum

Lily Carter, Vedika Apte, Arushi Shukla, Aruni Ghose, Raj Mamidi, Alexandra Petohazi, Shania Makker, Soirindhri Banerjee, Stergios Boussios, Giuseppe L. Banna

Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies

Mandy Jongbloed, Atulya A. Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K.M. De Ruysscher, Lizza E.L. Hendriks, Aakash Desai

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine